ESC 2016: PCSK9 Antagonists: A Real Breakthrough For Management Of Familial Hypercholesterolaemia?

Content for healthcare professionals only

View all Platforms Cardiology

Topics Content Type Videos Articles Journals Broadcasts Education Podcasts News Journals AER CFR ECR ICR3 JAPSC USC Faculty Events Upcoming Events Radcliffe Events All Events Resource Hubs Empagliflozin in the Treatment of Chronic Heart Failure Pulmonary Embolism Pulsed Field Ablation

Radcliffe Platforms

Radcliffe Group Cardiology Vascular CVRM Medical Education

Content for healthcare professionals only

Topics

Content Type

Journals

Faculty

Events

Resource Hubs

Video

ESC 2016: PCSK9 Antagonists: A Real Breakthrough For Management Of Familial Hypercholesterolaemia?

Published: 18 Aug 2016

Views:
192
Likes:
0

Average (ratings)

No ratings

Your rating

Professor Ulf Landmesser discusses "PCSK9 antagonists: a real breakthrough for management of familial hypercholesterolaemia?" at the 2016 ESC Congress in Rome, Italy.